Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Lifeist Wellness Inc V.LFST

Alternate Symbol(s):  LFSWF

Lifeist Wellness Inc. is a Canada-based health-tech company. The Company leverages advancements in science and technology to develop innovative products to support human wellness and transform lives. The Company's key asset is its United States biosciences subsidiary Mikra Cellular Sciences Inc. (Mikra), a biosciences and consumer wellness company focused on developing and selling products. Mikra's products consists of Focus, Protect, Serenity, and CELLF.


TSXV:LFST - Post by User

Bullboard Posts
Comment by blueboyon Dec 27, 2017 6:31am
232 Views
Post# 27228711

RE:Q4 Numbers And Forward looking Info, Your welcome

RE:Q4 Numbers And Forward looking Info, Your welcomeYes, N's sales are growing nicely but your numbers are flawed.  First of all, use market cap and not share price when comparing companies.  Secondly, N's quarters end in Sept and Dec, NOT Aug and Nov.  This quarter's revenues are almost as high in two months (Oct and Nov) than last quarter's revenue was in 3 months (July, Aug, Sept), so yes, this quarter will be their best quarterly revenues ever.  Another problem with comparing N to that group of stocks is that N does not yet sell MJ and most of those other ones do.

BB

Discomuff wrote: Q4 Results look something like this 

1)June 2017 $1,349,545.00 Can
2)July 2017 $1,196,971.00 Can
3)August 2017 $1,426,755.00 Can

 Totaling $3,969,675.00 Can 

Acording to the Revenue tracker this still places us in 9th place as followed,

Company / Quarterly Revenue / Share Price

1) Canopy Growth / 17.57M / $23.12
2) MedReleaf / 9.82M / $16.34                  
3) Aurora / 8.25M / $7.21
4) Canntrust / 6.14M / $8.35
5) Aphria/ 6.12M / $15.28
6) Isodiol International / 5.06M / $1.33
7) Cannimed Therapeutics / 4.77M / $19.95
8) MPX Bioceutical / 4.41M / $.44
9) NamasteTechnologies / 3.96M / $2.66

This is an increase from the Q3 results of about $3,130,00.00

Forward Looking into Q1 2018

1) September $1,198,765 Can
2) October $1,313,653 Can
3) November $2,221,340 Can

Totaling $4,733,758

As you can see the company is on track moving forward with future growth and revenue.
Q2 2018 and Q3 2018 will be very exciting times and we are going to see a whole new added revenue stream from medical Cannabis sales which will be doubling or tripling Quartery results




Bullboard Posts